| Literature DB >> 28319819 |
Juan A Ortega-García1, Fernando A López-Hernández2, Alberto Cárceles-Álvarez3, José L Fuster-Soler4, Diana I Sotomayor3, Rebeca Ramis5.
Abstract
AIM: Pediatric cancer has been associated with exposure to certain environmental carcinogens. The purpose of this work is to analyse the relationship between environmental pollution and pediatric cancer risk.Entities:
Keywords: Childhood cancer; Industrial pollution; Residential proximity; Spatial analysis; Urban pollution
Mesh:
Substances:
Year: 2017 PMID: 28319819 PMCID: PMC5685507 DOI: 10.1016/j.envres.2017.03.009
Source DB: PubMed Journal: Environ Res ISSN: 0013-9351 Impact factor: 6.498
Fig. 1Cases and foci of air-polluting industries in RM (urban areas Murcia y Cartagena).
List of industrial associated with each focus, industrial activity and population (< 15 years) exposed.
| Industrial activity | Population under 15 in 2011
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Foci | E | C | P | Ce | I | E-PRTR | 1 km | 3 km | 5 km | 10 km |
| Foci #1 | – | x | – | – | – | 6550 (20.53) | 0 | 6173 | 17732 | 38426 |
| Foci #2 | x | x | – | – | x | 722 (20.59); 1529 (19.20); 3442 (38.22); 3557 (20.59); 3589 (35.16); 3896 (20.14); 4791 (20.13); 5771 (52.10); 6515 (35.19); 6644 (35.16); 7733 (20.59); 7720 (20.14) | 0 | 1326 | 2461 | 17245 |
| Foci #3 | – | – | – | – | x | 3825 (38.22); 6251 (30.22); 7412 (81.22) | 0 | 6608 | 23118 | 28846 |
| Foci #4 | x | x | – | – | – | 1752 (20.16); 3965 (35.16) | 0 | 355 | 1927 | 2416 |
| Foci #5 | – | x | – | – | – | 6263 (20.41) | 0 | 4734 | 9847 | 20367 |
| Foci #6 | – | – | x | – | – | 4940 (21.10); 3490 (21.10) | 320 | 2365 | 4653 | 7930 |
| Foci #7 | – | – | – | – | x | 7750 (39.00) | 0 | 831 | 1629 | 2488 |
| Foci #8 | – | – | – | x | – | 9001 (23.51) | 0 | 110 | 624 | 729 |
| Foci #9 | – | – | – | x | – | 1574 (23.51) | 0 | 7750 | 11541 | 12192 |
| Foci #10 | – | x | x | – | – | 1702 (20.59); 1717 (21.10) | 426 | 6162 | 11406 | 17874 |
| Foci #11 | – | – | – | – | x | 3190 (38.21) | 0 | 414 | 682 | 5607 |
| Foci #12 | – | – | x | – | – | 6596 (21.10) | 0 | 0 | 3061 | 4021 |
E= energy industries; C= organic and inorganic chemical industries; P= pharmaceutical industries; Ce= building material industries; I= industries concerned with the incineration or valorisation of dangerous waste.
European Pollutant Release and Transfer Register. (http://prtr.ec.europa.eu/)
In brackets economic activity code.
Distribution of diagnosed cases. CR and SIR by type and period.
| Cases by period
| CR | Spain (00–13) | Europe (88–97) | SIR (CI 95%) by type and period in the RM
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98–03 | 04–09 | 10–15 | All | % | 98–03 | 04–09 | 10–15 | |||||
| Leukaemia | 44 | 55 | 72 | 171 | 27.4 | 40.5/41.2 | 46.1/47.0 | 41.7/44.1 | 0.91 (0.66–1.22) | 1.14 (0.86–1.42) |
| |
| ALL | 34 | 43 | 56 | 133 | 31.5/34.5 | 36.0/36.8 | 33.8/35.9 | 0.90 (0.62–1.26) | 1.14 (0.87–1.47) |
| ||
| AML | 9 | 12 | 11 | 32 | 7.6/7.8 | 8.3/8.3 | 6.2/6.4 | 0.98 (0.45–1.86) | 1.31 (0.75–2.12) | 1.20 (0.67–1.98) | ||
| Others | 1 | – | 5 | 6 | 1.4/1.5 | 1.9/1.9 | 0.68 (0.01–3.79) | – | 2.72 (0.93–6.24) | |||
| Lymphomas | 19 | 11 | 35 | 65 | 10.4 | 15.4/16.1 | 19.6/19.2 | 15.9/15.2 | 1.01 (0.61–1.58) | 0.59 (0.29–1.05) |
| |
| HL | 8 | 4 | 10 | 22 | 5.2/5.2 | 7.2/6.9 | 6.3/5.8 | 1.22 (0.52–2.40) | 0.61 (0.16–1.56) | 1.52 (0.73–2.80) | ||
| NHL | 11 | 7 | 25 | 43 | 10.2/11.0 | 12.4/12.4 | 9.6/9.3 | 0.90 (0.45–1.61) | 0.57 (0.23–1.18) |
| ||
| CNST | 43 | 47 | 56 | 146 | 23.4 | 34.6/35.6 | 34.2/34.5 | 29.4/29.9 | 1.03 (0.74–1.38) | 1.12 (0.82–1.49) | 1.31 (0.99–1.71) | |
| SNST | 14 | 15 | 31 | 60 | 9.6 | 14.2/14.5 | 13.1/13.8 | 9.4/10.9 | 0.83 (0.46–1.40) | 0.89 (0.50–1.47) |
| |
| Others | 52 | 62 | 68 | 182 | 29.2 | 43.2/43.8 | 40.8/41.3 | – | – | – | ||
| Total | 172 | 190 | 262 | 624 | 100 | 148.0/151.6 | 153.9/155.8 | 133.7/138.5 | 0.97 (0.83–1.12) | 1.06 (0.92–1.23) |
| |
| CR | 138.4 | 133.9 | 168.4 | 148.0 | ||||||||
CR = Crude rate 1000000 under 15; ASRw =age-world-standardized incidence rate; SIR = standardized incidence ratio; IC = confidence interval. ALL = acute lymphoblastic leukemias; AML = acute myeloblastic leukemias; HL = Hodking lymphomas; NHL = non Hodking lymphomas; CNST = central nervous system tumours; SNST = sympathetic nervous system tumours. Spanish data obtained from Peris Bonet el al. (2015). European data obtained from Steliarova-Foucher et al. (2002).
List of industrial activity and population (< 15 years) exposed less than 4 km.
| Foci Group | Population (< 15) in 2011 around focus | L | HL | NHL | CNST | SNST | Other | All | |
|---|---|---|---|---|---|---|---|---|---|
| All | 62473 | Observed (Expected) | 29 (35.87) | 5 (4.61) | 13 (8.58) | 30 (30.53) | 13 (12.71) | 36 (37.94) | 126 (130.24) |
| SIR | 0.81 | 1.08 | 1.52 | 0.98 | 1.02 | 0.95 | 0.97 | ||
| CI 95% (SIR) | (0.54,1.16) | (0.35,2.53) | (0.81,2.59) | (0.66,1.40) | (0.54,1.75) | (0.66,1.31) | (0.81,1.15) | ||
| p-value | 0.91 | 0.50 | 0.07 | 0.57 | 0.50 | 0.64 | 0.65 | ||
| CI 95% ratio λy/λx | (0.536,+∞) | (0.39,+∞) | (0.933,+∞) | (0.679,+∞) | (0.578,+∞) | (0.679,+∞) | (0.813,+∞) | ||
| Lowest (p-value) | 46 (0.03) | 9 (0.02) | 14 (0.03) | 40 (0.03) | 19 (0.03) | 48 (0.03) | 147 (0.05) | ||
| Power | 0.999 | 0.442 | 0.732 | 0.997 | 0.883 | 1.000 | 1.000 | ||
| E | 4388 | Observed | 1 (1.68) | 1 (0.21) | 0 (0.38) | 1 (1.41) | 3 (0.61) | 3 (1.75) | 9 (6.04) |
| SIR | 0.6 | 4.82 | – | 0.71 | 4.95 | 1.71 | 1.49 | ||
| CI | (0.02,3.33) | (0.12,26.84) | – | (0.02,3.95) | (1.02,14.48) | (0.35,5.00) | (0.68,2.83) | ||
| p-value | 0.80 | 0.19 | – | 0.75 | 0.02 | 0.24 | 0.14 | ||
| CI | (0.031,+∞) | (0.242,+∞) | – | (0.037,+∞) | (1.445,+∞) | (0.477,+∞) | (0.796,+∞) | ||
| Lowest (p-value) | 5 (0.02) | 2 (0.01) | 3 (0.00) | 5 (0.01) | 3 (0.02) | 5 (0.03) | 11 (0.03) | ||
| Power | 0.124 | 0.009 | 0.008 | 0.067 | 0.036 | 0.142 | 0.548 | ||
| C | 31967 | Observed | 9 (12.77) | 2 (1.62) | 5 (3.02) | 10 (10.83) | 8 (4.55) | 18 (13.47) | 52 (46.26) |
| SIR | 0.70 | 1.23 | 1.66 | 0.92 | 1.76 | 1.34 | 1.12 | ||
| CI 95% (SIR) | (0.32,1.34) | (0.15,4.45) | (0.54,3.87) | (0.44,1.70) | (0.76,3.46) | (0.79,2.11) | (0.84,1.47) | ||
| p-value | 0.89 | 0.49 | 0.18 | 0.64 | 0.07 | 0.11 | 0.19 | ||
| CI 95% ratio λy/λx | (0.358,+∞) | (0.208,+∞) | (0.647,+∞) | (0.491,+∞) | (0.911,+∞) | (0.881,+∞) | (0.889,+∞) | ||
| Lowest (p-value) | 19 (0.04) | 5 (0.02) | 7 (0.03) | 17 (0.04) | 9 (0.03) | 20 (0.04) | 58 (0.04) | ||
| Power | 0.887 | 0.110 | 0.262 | 0.813 | 0.426 | 0.897 | 1.000 | ||
| P | 14467 | Observed | 12 (9.69) | 2 (1.24) | 3 (2.32) | 9 (8.24) | 2 (3.43) | 8 (10.24) | 36 (35.16) |
| SIR | 1.24 | 1.61 | 1.30 | 1.09 | 0.58 | 0.78 | 1.02 | ||
| CI 95% (SIR) | (0.64,2.16) | (0.19,5.80) | (0.27,3.78) | (0.50,2.07) | (0.07,2.11) | (0.34,1.54) | (0.72,1.42) | ||
| p-value | 0.25 | 0.35 | 0.41 | 0.43 | 0.86 | 0.80 | 0.45 | ||
| CI 95% ratio λy/λx | (0.715,+∞) | (0.277,+∞) | (0.344,+∞) | (0.563,+∞) | (0.1,+∞) | (0.382,+∞) | (0.759,+∞) | ||
| Lowest (p-value) | 16 (0.03) | 4 (0.03) | 6 (0.02) | 14 (0.03) | 8 (0.02) | 16 (0.04) | 46 (0.03) | ||
| 0.736 | 0.106 | 0.187 | 0.676 | 0.253 | 0.808 | 0.999 | |||
| Ce | 12165 | Observed | 3 (7.24) | 3 (0.92) | 0 (1.72) | 8 (6.13) | 3 (2.57) | 13 (7.59) | 30 (26.17) |
| SIR | 0.41 | 3.27 | – | 1.3 | 1.17 | 1.71 | 1.15 | ||
| CI 95% (SIR) | (0.09,1.21) | (0.67,9.56) | – | (0.56,2.57) | (0.24,3.41) | (0.91,2.93) | (0.77,1.64) | ||
| p-value | 0.97 | 0.06 | – | 0.26 | 0.46 | 0.03 | 0.22 | ||
| CI 95% ratio λy/λx | (0.111,+∞) | (0.908,+∞) | – | (0.652,+∞) | (0.319,+∞) | (1.039,+∞) | (0.834,+∞) | ||
| Lowest (p-value) | 13 (0.02) | 4 (0.01) | 5 (0.02) | 11 (0.04) | 6 (0.04) | 13 (0.03) | 35 (0.04) | ||
| Power | 0.585 | 0.039 | 0.135 | 0.568 | 0.259 | 0.654 | 0.993 | ||
| I | 9847 | Observed | 8 (15.05) | 1 (1.95) | 6 (3.63) | 11 (12.85) | 4 (5.31) | 11 (15.97) | 41 (54.76) |
| SIR | 0.53 | 0.51 | 1.65 | 0.86 | 0.75 | 0.69 | 0.75 | ||
| CI 95% (SIR) | (0.23,1.05) | (0.01,2.85) | (0.61,3.60) | (0.43,1.53) | (0.21,1.93) | (0.34,1.23) | (0.54,1.02) | ||
| p-value | 0.98 | 0.87 | 0.15 | 0.74 | 0.79 | 0.92 | 0.98 | ||
| CI 95% ratio λy/λx | (0.249,+∞) | (0.024,+∞) | (0.722,+∞) | (0.463,+∞) | (0.243,+∞) | (0.371,+∞) | (0.549,+∞) | ||
| Lowest (p-value) | 22 (0.04) | 5 (0.04) | 8 (0.02) | 20 (0.03) | 10 (0.03) | 23 (0.04) | 68 (0.03) | ||
| Power | 0.922 | 0.199 | 0.305 | 0.848 | 0.494 | 0.938 | 1.000 |
Abbreviations: L = leukaemia; HL = Hodking lymphomas; NHL = non Hodking lymphomas; CNST = central nervous system tumours. SNST = sympathetic nervous system tumours.
E= energy industries; C= organic and inorganic chemical industries; P= pharmaceutical industries; Ce= building material industries; I= industries concerned with the incineration or valorisation of dangerous waste.
p-value (H0: λy/λx≤1; HA: λy/λx > 1). Assume that Y ∼ Poisson(nλy) and X ∼ Poisson(mλx). n=total population around (< 4 km) Foci; m=total population outside (≥4 km) Foci. Y = Cases around (< 4 km) Foci; X = Cases outside (≥4 km) Foci influence.
Exact confidence interval α=0.05 to the ratio λy/λx.
SIR=Standardize Incidence Ratio by age group with respect to Murcia Region.
Exact Confidence Interval α=0.05.
Lowest number of observed cases which would be statistical significant at the one sided 5% type one level or less test using this test. In brackets: Exact value of the one sided type one error corresponding to this limit.
List of industrial associated with each focus, industrial activity and population (< 15 years) exposed less than 4 km.
| Foci |
| Types of | Population (< 15) around | L | HL | NHL | CNST | SNST | Others | All | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Foci #1 | 1 | C | 17732 | Observed (Expected) | 5 (7.27) | 1 (0.93) | 2 (1.74) | 7 (6.19) | 5 (2.58) | 10 (7.68) | 30 (26.39) |
| SIR | 0.69 (0.22,1.60) | 1.07(0.03,5.97) | 1.15 (0.14,4.16) | 1.13(0.45,2.33) | 1.94 (0.63,4.52) | 1.30 (0.62,2.39) | 1.14 (0.77,1.62) | ||||
| p-value | 0.85 | 0.61 | 0.52 | 0.42 | 0.11 | 0.23 | 0.25 | ||||
| CI | (0.26,+∞) | (0.05,+∞) | (0.19,+∞) | (0.52,+∞) | (0.77,+∞) | (0.71,+∞) | (0.82,+∞) | ||||
| Lowest (p-value) | 13 (0.03) | 4 (0.01) | 5 (0.02) | 11 (0.04) | 6 (0.04) | 13 (0.04) | 36 (0.03) | ||||
| Power | 0.592 | 0.041 | 0.140 | 0.581 | 0.262 | 0.670 | 0.992 | ||||
| Foci #2 | 12 | E; C; I | 2461 | Observed | 0 (0.90) | 0 (0.11) | 0 (0.21) | 0 (0.76) | 1 (0.32) | 0 (0.95) | 1 (3.25) |
| SIR (CI | – | – | – | – | 3.12 (0.08,17.40) | – | 0.31 (0.01,1.71) | ||||
| p-value | – | – | – | – | 0.26 | – | 0.96 | ||||
| CI 95% ratio λ | – | – | – | – | (0.16,+∞) | – | (0.01,+∞) | ||||
| Lowest (p-value) | 4 (0.01) | 2 (0.00) | 2 (0.01) | 3 (0.04) | 2 (0.03) | 4 (0.01) | 7 (0.04) | ||||
| Power | 0.036 | 0.002 | 0.009 | 0.068 | 0.027 | 0.044 | 0.327 | ||||
| Foci #3 | 3 | I | 23118 | Observed | 7 (13.07) | 1 (1.70) | 5 (2.06) | 10 (11.16) | 3 (4.61) | 9 (13.87) | 35 (47.57) |
| SIR (CI | 0.54 (0.22,1.10) | 0.59 (0.01,3.28) | 2.43 (0.79,5.68) | 0.90 (0.43,1.65) | 0.65 (0.13,1.90) | 0.65 (0.30,1.23) | 0.74 (0.51,1.02) | ||||
| p-value | 0.98 | 0.82 | 0.05 | 0.68 | 0.85 | 0.93 | 0.98 | ||||
| CI 95% ratio λ | (0.23,+∞) | (0.02,+∞) | (0.98,+∞) | (0.47,+∞) | (0.16,+∞) | (0.32,+∞) | (0.52,+∞) | ||||
| Lowest (p-value) | 20 (0.03) | 5 (0.02) | 6 (0.01) | 18 (0.03) | 9 (0.04) | 21 (0.03) | 60 (0.03) | ||||
| Power | 0.867 | 0.129 | 0.124 | 0.787 | 0.442 | 0.885 | 1.000 | ||||
| Foci #4 | 2 | E; C | 1927 | Observed | 1 (0.78) | 1 (0.09) | 0 (0.17) | 1 (0.65) | 2 (0.29) | 3 (0.81) | 8 (2.79) |
| SIR (CI | 1.28 (0.03,7.15) | 10.7 (0.27,59.60) | – | 1.54 (0.04,8.59) | 7.01 (0.85,25.33) | 3.72 (0.77,10.86) | 2.87(1.24,5.66) | ||||
| p-value | 0.52 | 0.09 | – | 0.46 | 0.02 | 0.04 | 0.00 | ||||
| CI 95% ratio λ | (0.06,+∞) | (0.53,+∞) | – | (0.08,+∞) | (1.3,+∞) | (1.05,+∞) | (1.48,+∞) | ||||
| Lowest (p-value) | 3 (0.03) | 2 (0.00) | 2 (0.01) | 3 (0.02) | 2 (0.02) | 3 (0.04) | 7 (0.02) | ||||
| Power | 0.073 | 0.001 | 0.005 | 0.043 | 0.021 | 0.082 | 0.198 | ||||
| Foci #5 | 1 | C | 9847 | Observed | 3 (3.82) | 0 (0.48) | 3 (0.89) | 2 (3.24) | 0 (1.37) | 5 (4.03) | 13 (13.84) |
| SIR (CI | 0.78 (0.16,2.29) | – | 3.35 (0.69,9.80) | 0.62 (0.07,2.23) | – | 1.24 (0.40,2.89) | 0.94 (0.50,1.61) | ||||
| p-value | 0.72 | – | 0.06 | 0.83 | – | 0.36 | 0.61 | ||||
| CI 95% ratio λ | (0.21,+∞) | – | (0.91,+∞) | (0.10,+∞) | – | (0.49,+∞) | (0.55,+∞) | ||||
| Lowest (p-value) | 8 (0.03) | 3 (0.01) | 4 (0.01) | 7 (0.04) | 4 (0.04) | 8 (0.04) | 21 (0.03) | ||||
| Power | 0.357 | 0.017 | 0.035 | 0.324 | 0.143 | 0.416 | 0.880 | ||||
| Foci #6 | 2 | P | 4653 | Observed | 3 (2.56) | 0 (0.33) | 0 (0.61) | 3 (2.18) | 0 (0.91) | 1 (2.71) | 7 (9.30) |
| SIR (CI | 1.17 (0.24,3.43) | – | – | 1.38 (0.28,4.02) | – | 0.37 (0.01,2.06) | 0.75 (0.30,1.55) | ||||
| p-value | 0.47 | – | – | 0.37 | – | 0.93 | 0.81 | ||||
| CI 95% ratio λ | (0.31,+∞) | – | – | (0.37,+∞) | – | (0.01,+∞) | (0.35,+∞) | ||||
| Lowest (p-value) | 6 (0.04) | 2 (0.04) | 3 (0.02) | 6 (0.02) | 4 (0.01) | 7 (0.01) | 15 (0.04) | ||||
| 0.256 | 0.029 | 0.036 | 0.151 | 0.038 | 0.181 | 0.758 | |||||
| Foci #7 | 1 | I | 1629 | Observed | 1 (1.06) | 0 (0.14) | 0 (0.26) | 1 (0.90) | 0 (0.37) | 2 (1.12) | 4 (3.85) |
| SIR (CI | 0.95 (0.02,5.27) | – | – | 1.11 (0.03,6.16) | – | 1.79 (0.22,6.46) | 1.04 (0.28,2.66) | ||||
| p-value | 0.65 | – | – | 0.59 | – | 0.30 | 0.53 | ||||
| CI 95% ratio λ | (0.04,+∞) | – | – | (0.05,+∞) | – | (0.31,+∞) | (0.35,+∞) | ||||
| Lowest (p-value) | 4 (0.02) | 2 (0.00) | 2 (0.02) | 4 (0.01) | 3 (0.00) | 4 (0.02) | 8 (0.04) | ||||
| 0.064 | 0.003 | 0.016 | 0.036 | 0.007 | 0.077 | 0.366 | |||||
| Foci#8 | 1 | Ce | 624 | Observed | 0 (0.38) | 0 (0.05) | 0 (0.09) | 0 (0.32) | 0 (0.13) | 0 (0.40) | 0 (1.38) |
| SIR (CI | – | – | – | – | – | – | – | ||||
| CI 95% (SIR) | – | – | – | – | – | – | – | ||||
| p-value | – | – | – | – | – | – | – | ||||
| CI 95% ratio λ | – | – | – | – | – | – | – | ||||
| Lowest (p-value) | 3 (0.00) | 1 (0.04) | 2 (0.00) | 2 (0.04) | 2 (0.00) | 3 (0.00) | 5 (0.01) | ||||
| Power | 0.008 | 0.005 | 0.001 | 0.027 | 0.002 | 0.009 | 0.062 | ||||
| Foci#9 | 1 | Ce | 11541 | Observed | 3 (6.86) | 3 (0.87) | 0 (1.62) | 8 (5.81) | 3 (2.44) | 13 (7.20) | 30 (24.79) |
| SIR (CI | 0.44 (0.09,1.28) | 3.46 (0.71,10.10) | – | 1.38 (0.59,2.71) | 1.23 (0.25,3.59) | 1.81 (0.96,3.09) | 1.21 (0.82,1.73) | ||||
| p-value | 0.96 | 0.05 | – | 0.22 | 0.42 | 0.02 | 0.15 | ||||
| CI 95% ratio λ | (0.11,+∞) | (0.96,+∞) | – | (0.69,+∞) | (0.33,+∞) | (1.09,+∞) | (0.88,+∞) | ||||
| Lowest (p-value) | 12 (0.04) | 4 (0.01) | 5 (0.02) | 11 (0.03) | 6 (0.03) | 13 (0.02) | 34 (0.03) | ||||
| Power | 0.613 | 0.032 | 0.110 | 0.494 | 0.220 | 0.577 | 0.987 | ||||
| Foci#10 | 2 | C; P | 11406 | Observed | 8 (6.16) | 2 (0.80) | 3 (1.49) | 5 (5.26) | 2 (2.17) | 7 (6.52) | 27 (22.41) |
| SIR (CI | 1.3 (0.56,2.56) | 2.5 (0.30,9.04) | 2.01 (0.41,5.87) | 0.95 (0.31,2.22) | 0.92 (0.11,3.33) | 1.07 (0.43,2.21) | 1.2 (0.79,1.75) | ||||
| p-value | 0.27 | 0.18 | 0.18 | 0.60 | 0.64 | 0.47 | 0.18 | ||||
| CI 95% ratio λ | (0.64,+∞) | (0.44,+∞) | (0.54,+∞) | (0.36,+∞) | (0.15,+∞) | (0.50,+∞) | (0.85,+∞) | ||||
| Lowest (p-value) | 11 (0.04) | 3 (0.04) | 5 (0.01) | 10 (0.03) | 6 (0.02) | 12 (0.03) | 31 (0.04) | ||||
| Power | 0.574 | 0.079 | 0.082 | 0.482 | 0.149 | 0.541 | 0.981 | ||||
| Foci#11 | 1 | I | 682 | Observed | 0 (0.27) | 0 (0.04) | 1 (0.07) | 0 (0.23) | 0 (0.09) | 0 (0.29) | 1 (0.97) |
| SIR(CI | – | – | 15.33 (0.39,85.43) | – | – | – | 1.03 (0.03,5.72) | ||||
| p-value | – | – | 0.06 | – | – | – | 0.62 | ||||
| CI 95% ratio λ | – | – | (0.783,+∞) | – | – | – | (0.05,+∞) | ||||
| Lowest (p-value) | 2 (0.031) | 1 (0.03) | 2 (0.00) | 2 (0.02) | 2 (0.00) | 2 (0.03) | 4 (0.01) | ||||
| Power | 0.018 | 0.003 | 0.000 | 0.012 | 0.001 | 0.021 | 0.047 | ||||
| Foci#12 | 1 | P | 3061 | Observed | 1 (0.96) | 0 (0.12) | 0 (0.21) | 1 (0.80) | 0 (0.35) | 0 (1.00) | 2 (3.45) |
| SIR(CI | 1.04 (0.03,5.78) | – | – | – | – | – | 0.58 (0.07,2.09) | ||||
| p-value | 0.60 | – | – | – | – | – | 0.84 | ||||
| CI 95% ratio λ | (0.05,+∞) | – | – | – | – | – | (0.10,+∞) | ||||
| Lowest (p-value) | 4 (0.01) | 2 (0.00) | 2 (0.02) | 3 (0.04) | 2 (0.04) | 4 (0.01) | 8 (0.02) | ||||
| Power | 0.046 | 0.002 | 0.009 | 0.079 | 0.034 | 0.053 | 0.258 |
Abbreviations: L = leukaemia; HL = Hodking lymphomas; NHL = non Hodking lymphomas; CNST = central nervous system tumours. SNST = sympathetic nervous system tumours.
p-value (H: λ/λ≤1; H: λ/λ > 1). Assume that Y ∼ Poisson(nλ) and X ∼ Poisson(mλ). n=total population around (< 4 km) Foci; m=total population outside (≥4 km) Foci. Y = Cases around (< 4 km) Foci; X = Cases outside (≥4 km) Foci influence.
Exact confidence interval α=0.05 to the ratio λ/λ.
SIR=Standardize Incidence Ratio by age group with respect to Murcia Region.
Exact Confidence Interval α=0.05.
Lowest number of observed cases which would be statistical significant at the one sided 5% type one level or less test using this test. In brackets: Exact value of the one sided type one error corresponding to this limit.
E= energy industries; C= organic and inorganic chemical industries; P= pharmaceutical industries; Ce= building material industries; I= industries concerned with the incineration or valorisation of dangerous waste.
Focused space Scan test results by tumour type and type of industry.
| Energy | Chemical | Pharmaceutical | Building material | Dangerous waste | All foci | ||
|---|---|---|---|---|---|---|---|
| All | #CT en MLC |
| 4 | 5 | 25 | 6 | 4 |
| Foci |
| Foci #4 | Foci #10 | Foci #9 | Foci #3 | Foci #4 | |
| Population |
| 1017 | 5993 | 6093 | 1786 | 1017 | |
| Km |
| 3.62 | 2.75 | 2.23 | 2.00 | 3.39 | |
| Number of cases |
| 8 | 25 | 22 | 5 | 8 | |
| Expected cases |
| 2.68 | 15.77 | 16.03 | 4.7 | 2.68 | |
| Annual cases/106 |
| 43.7 | 23.2 | 20.1 | 15.6 | 43.7 | |
| p-value |
| 0.13 | 0.21 | 0.26 | 0.99 | 0.27 | |
| Leukaemia | # CT en MLC | 7 | 25 | 15 | – | – | 15 |
| Foci | Foci #4 | Foci #10 | Foci #12 | – | – | Foci #12 | |
| Population | 1750 | 5993 | 2807 | – | – | 2807 | |
| Km | 4.80 | 2.75 | 4.74 | – | – | 4.74 | |
| Number of cases | 2 | 7 | 6 | – | – | 6 | |
| Expected cases | 1.27 | 4.34 | 2.03 | – | – | 2.03 | |
| Annual cases/106 | 6.3 | 6.5 | 11.9 | – | – | 11.9 | |
| p-value | 0.58 | 0.88 | 0.15 | – | – | 0.45 | |
| CNST | #CT en MLC | – | 17 | 22 | 8 | 62 | 17 |
| Foci | – | Foci #1 | Foci #10 | Foci #9 | Foci #3 | Foci#1 | |
| Population | – | 3418 | 5487 | 1725 | 10458 | 3418 | |
| Km | – | 2.04 | 2.65 | 2.30 | 3.20 | 2.04 | |
| Number of cases | – | 5 | 5 | 3 | 8 | 5 | |
| Expected cases | – | 2.11 | 3.39 | 1.07 | 6.46 | 2.11 | |
| Annual cases/106 | – | 8.1 | 5.1 | 2.86 | 4.3 | 8.1 | |
| p-value | – | 0.62 | 0.79 | 0.25 | 0.82 | 0.84 | |
| SNST | #CT en MLC |
| 58 | 37 | 24 | 9 | 4 |
| Foci |
| Foci #1 | Foci #10 | Foci #9 | Foci #2 | Foci #4 | |
| Population |
| 12453 | 8991 | 6093 | 2019 | 1017 | |
| Km |
| 4.44 | 4.27 | 2.99 | 4.73 | 3.39 | |
| Number of cases |
| 7 | 3 | 3 | 2 | 2 | |
| Expected cases |
| 3.18 | 2.20 | 1.56 | 0.52 | 0.26 | |
| Annual cases/106 |
| 3.1 | 1.9 | 2.7 | 5.5 | 10.9 | |
| p-value |
| 0.41 | 0.74 | 0.30 | 0.43 | 0.46 | |
| NHL | #CT en MLC |
|
| 15 | – |
|
|
| Foci |
|
| Foci #10 | – |
|
| |
| Population |
|
| 3838 | – |
|
| |
| Km |
|
| 2.36 | – |
|
| |
| Number of cases |
|
| 3 | – |
|
| |
| Expected cases |
|
| 0.67 | – |
|
| |
| Annual cases/106 |
|
| 4.3 | – |
|
| |
| p-value |
|
| 0.151 | – |
|
| |
| HL | #CT en MLC | – | 13 | 13 |
| 80 | 32 |
| Foci | – | Foci #10 | Foci #10 |
| Foci #3 | Foci #9 | |
| Population | – | 3462 | 3462 |
| 20640 | 7493 | |
| Km | – | 2.26 | 2.26 |
| 4.35 | 3.37 | |
| Number of cases | – | 2 | 2 |
| 2 | 3 | |
| Expected cases | – | 0.32 | 0.32 |
| 1.93 | 0.7 | |
| Annual cases/106 | – | 3.2 | 3.2 |
| 0.5 | 2.2 | |
| p-value | – | 0.26 | 0.127 |
| 0.612 | 0.360 |
CT = Census track; MLC =Most Likelihood Cluster; Population = Population (< 15) inside of MLC; Km = radius of MLC around foci; Number of cases= Number of cases inside of cluster; Expected cases= Expected cases inside of cluster.
Abbreviations: L = leukaemia; HL = Hodking lymphomas; NHL = non Hodking lymphomas; CNST = central nervous system tumours. SNST = sympathetic nervous system tumours
p-value < 0.05.
p-value < 0.1.